Concentrations and origins of soluble interleukin 6 receptor-α in serum and synovial fluid

Journal of Rheumatology

Volumn 24, Issue 8, 1997, Pages 1510-1516

  Desgeorges, Alain ^a   Gabay, Cem ^a   Silacci, Paolo ^a   Novick, Daniela ^a,c   Roux Lombard, Pascale ^a   Grau, Georges ^a,d   Dayer, Jean Michel ^a   Vischer, Thomas ^a,b   Guerne, Pierre Andre ^a,e  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b Department of Medicine ^*  (Switzerland)

^c WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^d UNIVERSITY OF GENEVA   (Switzerland)

^e Univ Hospital Beau Séjour   (Switzerland)

Author keywords

chondrocytes; hepatocytes; interleukin 6; serum; soluble interleukin 6 receptor alpha; synovial fluid

Indexed keywords

INTERLEUKIN 6 RECEPTOR;

ADULT; AGED; ARTHROPATHY; ARTICLE; CARTILAGE CELL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; LIVER CELL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RHEUMATIC DISEASE; SERUM; SYNOVIAL FLUID;

ANTIGENS, CD; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; GROWTH INHIBITORS; HUMANS; INTERLEUKIN-6; LEUKOCYTE COUNT; LEUKOCYTES, MONONUCLEAR; LIVER; NEUTROPHILS; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-6; RHEUMATIC DISEASES; SYNOVIAL FLUID;

EID: 0030760235     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Van Snick, J: Interleukin-6: An overview. Annu Rev Immunol 1990;8:253-78.
2. Akira S, Taga T, Kishimoto T: Interleukin-6 in biology and medicine. Adv Immunol 1993;54:1-78.
3. Yamasaki K, Taga T, Hirata Y, Yawata H, Kawanishi Y, Seed B: Cloning and expression of the human interleukin-6 (BSF-2/IFN beta 2) receptor. Science 1988;241:825-8.
4. Taga T, Hibi M, Hirata Y, et al: Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130. Cell 1989;58:573-81.
5. Hibi M, Murakami M, Saito M, Hirano T, Taga T, Kishimoto T: Molecular cloning and expression of an IL-6 signal transducer, gp130. Cell 1990;63:1149-57.
6. Yasukawa K, Saito T, Fukunaga T, et al: Purification and characterization of soluble human IL-6 receptor expressed in CHO cell. J Biochem 1990;108:673-6.
7. Novick D, Engelmann H, Wallach D, Rubinstein M: Soluble cytokine receptors are present in normal human urine. J Exp Med 1989;170:1409-14.
8. Tamura T, Udgawa N, Takashi N, et al: Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6. Proc Natl Acad Sci USA 1993;90:11294-8.
9. Mackiewicz A, Schooltink H, Heinrich PC, Rose-John S: Complex of soluble human IL-6-receptor/IL-6 upregulates expression of acute phase proteins. J Immunol 1992;149:2021-7.
10. Taga T, Kishimoto T: Role of a two-chain IL-6 receptor system in immune and hematopoietic cell regulation. Crit Rev Immunol 1992;11:265-80.
11. Bauer J, Bauer TM, Kalb T, et al: Regulation of interleukin 6 receptor expression in human monocytes and monocyte-derived macrophages. Comparison with the expression in human hepatocytes. J Exp Med 1989;170:1537-49.
12. Guerne P-A, Zuraw BL, Vaughan JH, Carson DA, Lotz M: Synovium as a source of interleukin 6 in vitro. Contribution to local and systemic manifestations of arthritis. J Clin Invest 1989;83:585-92.
13. Waage A, Kaufmann C, Espevik T, Husby G: Interleukin-6 in synovial fluid from patients with arthritis. Clin Immunol Immunopathol 1989;50:394-8.
14. Miyasaka N, Sato K, Hashimoto J, et al: Constitutive production of interleukin 6/B cell stimulatory factor-2 from inflammatory synovium. Clin Immunol Immunopathol 1989;52:238-47.
15. Hovdenes J, Kvien TK, Hovdenes AB: IL-6 in synovial fluids, plasma and supernatants from cultured cells of patients with rheumatoid arthritis and other inflammatory arthritides. Scand J Rheumatol 1990;19:177-82.
16. Guerne P-A, Carson DA, Lotz M: IL-6 production by human articular chondrocytes: Modulation of its synthesis by cytokines, growth factors, and hormones in vitro. J Immunol 1990;144:499-505.
17. Bender S, Haubeck HD, Van de Leur E, et al: Interleukin-1 beta induces synthesis and secretion of interleukin-6 in human chondrocytes. FEBS Lett 1990;263:321-4.
18. Lotz M, Guerne P-A: Interleukin-6 induces the synthesis of tissue inhibitor of metalloproteinase-1/erythroid potentiating activity. J Biol Chem 1991;266:2011-20.
19. Altman RD: The classification of osteoarthritis. J Rheumatol 1995;(suppl 43)22:42-3.
20. Arnett FC, Edworthy SM, Bloch DA, et al: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1987;31:315-24.
21. Tan EM, Cohen AS, Fries JF, et al: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
22. Haslett C, Guthrie LA, Kopaniak MM, Johnston RB Jr, Henson PM: Modulation of multiple neutrophil functions by preparative methods or trace concentrations of bacterial lipopolysaccharide. Am J Pathol 1985;119:101-10.
23. Lotz M, Clark-Lewis I, Ganu V: HIV-1 transactivator protein Tat induces proliferation and TGFß expression in human articular chondrocytes. J Cell Biol 1994;124:365-71.
24. Grau GE, Mili N, Lou JN, et al: Phenotypic and functional analysis of pulmonary microvascular endothelial cells from patients with acute respiratory distress syndrome. Lab Invest 1996;74:761-70.
25. Novick D, Engelmann H, Revel M, Leitner O, Rubinstein M: Monoclonal antibodies to the soluble human IL-6 receptor: Affinity purification, ELISA, and inhibition of ligand binding. Hybridoma 1991;10:137-46.
26. Frieling JTM, Sauerwein RW, Wijdenes J, Hendriks T, van der Linden CJ: Soluble interleukin 6 receptor in biological fluids from human origin. Cytokine 1994;6:376-81.
27. Kotake S, Sato K, Kim KJ, et al: Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation. J Bone Miner Res 1996;11:88-95.
28. Frieling JTM, van Deuren M, Wijdenes J, et al: Circulating interleukin-6 receptor in patients with sepsis syndrome. J Infect Dis 1995;171:469-72.
29. De Benedetti F, Massa M, Pignatti P, Albani S, Novick D, Martini A: Serum soluble interleukin 6 (IL-6) receptor and IL-6/soluble IL-6 receptor complex in systemic juvenile rheumatoid arthritis. J Clin Invest 1994;93:2114-9.
30. Gaillard JP, Bataille R, Brailly H, et al: Increased and highly stable levels of functional interleukin 6 receptor in sera of patients with monoclonal gammopathy. Eur J Immunol 1993;23:820-4.
31. Honda M, Yammamoto S, Cheng M, et al: Human soluble IL-6 receptor. Its detection and enhanced released by HIV infection. J Immunol 1992;148:2175-80.
32. Gabay C, Roux-Lombard P, De Moerloose P, Dayer J-M, Vischer T, Guerne P-A: Absence of correlation between interleukin 6 and C-reactive protein blood levels in systemic lupus erythematosus compared with rheumatoid arthritis. J Rheumatol 1993;20:815-21.
33. Peters M, Jacobs S, Ehlers M, et al: The function of the soluble interleukin 6 (IL-6) receptor in vivo: Sensitization of human soluble IL-6 receptor transgenic mice towards IL-6 and prolongation of the plasma half-life of IL-6. J Exp Med 1996;183:1399-406.
34. Rose-John S, Schooltink H, Lenz D, et al: Studies on the structure and regulation of the human hepatic interleukin-6 receptor. Eur J Biochem 1990;190:79-83.
35. Gabay C, Silacci P, Genin B, Mentha G, Le Coultre C, Guerne PA: Soluble interleukin-6 receptor strongly increases the production of acute-phase protein by hepatoma cells but exerts minimal changes on human primary hepatocytes. Eur J Immunol 1995;25:2378-83.
36. Müllberg J, Schooltink H, Stoyan T, et al: The soluble interleukin-6 receptor is generated by shedding. Eur J Immunol 1993;23:473-80.
37. Horiuchi S, Koyanagi Y, Zhou Y, et al: Soluble interleukin-6 receptors released from T cell or granulocyte/macrophage cell lines and human peripheral blood mononuclear cells are generated through an alternative splicing mechanism. Eur J Immunol 1994;24:1945-8.